Phase III Trial Launched of Ebola Vaccine

"There has been massive mobilization on the part of the affected countries and all partners to accelerate the development and availability of proven interventions. If a vaccine is found effective, it will be the first preventive tool against Ebola in history," said WHO Director-General Dr. Margaret Chan.

The World Health Organization, the Health Ministry of Guinea, Médecins Sans Frontières, Epicentre, and The Norwegian Institute of Public Health launched a Phase III trial of the VSV-EBOV vaccine in Guinea. The trial is based on promising data from initial clinical trials in late 2014 and will test the vaccine's efficacy and effectiveness to prevent Ebola. The vaccine was developed by the Public Health Agency of Canada; a second vaccine will be tested in a sequential study, as supply becomes available, according to WHO.

"We have worked hard to reach this point," said WHO Director-General Dr. Margaret Chan. "There has been massive mobilization on the part of the affected countries and all partners to accelerate the development and availability of proven interventions. If a vaccine is found effective, it will be the first preventive tool against Ebola in history."

Vaccinations will take place in areas of Basse Guinée, the region that currently has the highest number of cases in the country, with a "ring vaccination" strategy being used, based on the approach used to eradicate smallpox in the 1970s. This involves identifying a newly diagnosed Ebola case – the "index case" – and tracing all of that person's contacts, who are then vaccinated if they give their consent.

"The Ebola epidemic shows signs of receding, but we cannot let down our guard until we reach zero cases," said Assistant Director-General Marie-Paule Kieny, who leads the Ebola Research and Development effort at WHO. "An effective vaccine to control current flare-ups could be the game changer to finally end this epidemic and an insurance policy for any future ones."

Download Center

  • Safety Metrics Guide

    Is your company leveraging its safety data and analytics to maintain a safe workplace? With so much data available, where do you start? This downloadable guide will give you insight on helpful key performance indicators (KPIs) you should track for your safety program.

  • Job Hazard Analysis Guide

    This guide includes details on how to conduct a thorough Job Hazard Analysis, and it's based directly on an OSHA publication for conducting JHAs. Learn how to identify potential hazards associated with each task of a job and set controls to mitigate hazard risks.

  • A Guide to Practicing “New Safety”

    Learn from safety professionals from around the world as they share their perspectives on various “new views” of safety, including Safety Differently, Safety-II, No Safety, Human and Organizational Performance (HOP), Resilience Engineering, and more in this helpful guide.

  • Lone Worker Safety Guide

    As organizations digitalize and remote operations become more commonplace, the number of lone workers is on the rise. These employees are at increased risk for unaddressed workplace accidents or emergencies. This guide was created to help employers better understand common lone worker risks and solutions for lone worker risk mitigation and incident prevention.

  • EHS Software Buyer's Guide

    Learn the keys to staying organized, staying sharp, and staying one step ahead on all things safety. This buyer’s guide is designed for you to use in your search for the safety management solution that best suits your company’s needs.

  • Vector Solutions

OH&S Digital Edition

  • OHS Magazine Digital Edition - June 2022

    June 2022

    Featuring:

    • SAFETY CULTURE
      Corporate Safety Culture Is Workplace Culture
    • HEAT STRESS
      Keeping Workers Safe from Heat-Related Illnesses & Injuries
    • EMPLOYEE HEALTH SCREENING
      Should Employers Consider Oral Fluid Drug Testing?
    • PPE FOR WOMEN
      Addressing Physical Differences
    View This Issue